Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 578784100 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Paradigm Biocapital Advisors LP
13G/A
Amendment 1
|
0% |
8/14/2026
Event 6/30/2026
|
|
| Paradigm BioCapital Advisors LP | 0% | ||
| Paradigm BioCapital Advisors GP LLC | 0% | ||
| Senai Asefaw, M.D. | 0% | ||
| Paradigm BioCapital International Fund Ltd. | 0% | ||
| BlackRock, Inc. 13G | 5.4% |
7/29/2026
Event 6/30/2026
|
|
| Janus Henderson Group PLC 13G/A Amendment 3 | 5.8% |
5/15/2026
Event 3/31/2026
|
|
|
Paradigm Biocapital Advisors LP
13G
|
6.1% |
4/1/2026
Event 3/25/2026
|
|
| Paradigm BioCapital Advisors LP | 6.1% | ||
| Paradigm BioCapital Advisors GP LLC | 6.1% | ||
| Senai Asefaw, M.D. | 6.1% | ||
| Paradigm BioCapital International Fund Ltd. | 5.4% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 4
|
9.0% |
2/13/2026
Event 12/31/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 9.0% | ||
| FHMLSP, L.P. | 9.0% | ||
| FHMLSP, L.L.C. | 9.0% | ||
| Frazier Life Sciences X, L.P. | 0.2% | ||
| FHMLS X, L.P. | 0.2% | ||
| FHMLS X, L.L.C. | 0.2% | ||
| Frazier Life Sciences XI, L.P. | 0.3% | ||
| FHMLS XI, L.P. | 0.3% | ||
| FHMLS XI, L.L.C. | 0.3% | ||
| Frazier Life Sciences XII, L.P. | 0% | ||
| FHMLS XII, L.P. | 0% | ||
| FHMLS XII, L.L.C. | 0% | ||
| James N. Topper | 0.2% | ||
| Patrick J. Heron | 0.2% | ||
|
Third Rock Ventures IV, L.P.
13G/A
Amendment 1
|
9.3% |
2/13/2026
Event 12/31/2025
|
|
| Third Rock Ventures IV, L.P. | 9.3% | ||
| Third Rock Ventures GP IV, L.P. | 9.3% | ||
| TRV GP IV, LLC | 9.3% | ||
| Third Rock Ventures V, L.P. | 2.0% | ||
| Third Rock Ventures GP V, L.P. | 2.0% | ||
| TRV GP V, LLC | 2.0% | ||
|
GV 2019, L.P.
13G/A
Amendment 1
|
2.9% |
2/6/2026
Event 12/31/2025
|
|
| GV 2019, L.P. | 1.6% | ||
| GV 2019 GP, L.P. | 1.6% | ||
| GV 2019 GP, L.L.C. | 1.6% | ||
| GV 2023, L.P. | 1.3% | ||
| GV 2023 GP, L.P. | 1.3% | ||
| GV 2023 GP, L.L.C. | 1.3% | ||
| Alphabet Holdings LLC | 2.9% | ||
| XXVI Holdings Inc. | 2.9% | ||
| Alphabet Inc. | 2.9% | ||
| Janus Henderson Group PLC 13G/A Amendment 2 | 7.3% |
11/14/2025
Event 9/30/2025
|
|
|
Foresite Capital Fund IV, L.P.
13G/A
Amendment 1
|
1.4% |
11/14/2025
Event 9/30/2025
|
|
| Foresite Capital Fund IV, L.P. | 1.2% | ||
| Foresite Capital Management IV, LLC | 1.2% | ||
| Foresite Capital Fund V, L.P. | 0.2% | ||
| Foresite Capital Management V, LLC | 0.2% | ||
| James Tananbaum | 1.4% | ||
|
Matrix Capital Management Company, LP
13G/A
Amendment 1
|
3.5% |
11/13/2025
Event 9/30/2025
|
|
| Matrix Capital Management Company, LP | 3.5% | ||
| David E. Goel | 3.5% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 3
|
7.7% |
8/14/2025
Event 6/30/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 7.7% | ||
| FHMLSP, L.P. | 7.7% | ||
| FHMLSP, L.L.C. | 7.7% | ||
| Frazier Life Sciences Public Overage Fund, L.P. | 2.3% | ||
| FHMLSP Overage, L.P. | 2.3% | ||
| FHMLSP Overage, L.L.C. | 2.3% | ||
| Frazier Life Sciences X, L.P. | 0.2% | ||
| FHMLS X, L.P. | 0.2% | ||
| FHMLS X, L.L.C. | 0.2% | ||
| Frazier Life Sciences XI, L.P. | 0.3% | ||
| FHMLS XI, L.P. | 0.3% | ||
| FHMLS XI, L.L.C. | 0.3% | ||
| James N. Topper | 0.2% | ||
| Patrick J. Heron | 0.2% | ||
| Albert Cha | 0% | ||
| James Brush | 0% | ||
| Daniel Estes | 0% | ||
| Janus Henderson Group PLC 13G/A Amendment 1 | 6.0% |
8/14/2025
Event 3/31/2025
|
|
|
Deep Track Capital, LP
13G/A
Amendment 1
|
9.0% |
8/14/2025
Event 6/30/2025
|
|
| Deep Track Capital, LP | 9.0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 9.0% | ||
| David Kroin | 9.0% | ||
|
ARCH Venture Fund X, L.P.
13G
|
9.4% |
5/15/2025
Event 3/31/2025
|
|
| ARCH Venture Fund X, L.P. | 9.4% | ||
| ARCH Venture Fund X Overage, L.P. | 9.4% | ||
| ARCH Venture Partners X, L.P. | 9.4% | ||
| ARCH Venture Partners X Overage, L.P. | 9.4% | ||
| ARCH Venture Partners X, LLC | 9.4% | ||
| Keith Crandell | 9.4% | ||
| Kristina Burow | 9.4% | ||
| Steven Gillis | 9.4% | ||
| Robert Nelsen | 9.4% | ||
| Janus Henderson Group PLC 13G | 5.7% |
5/14/2025
Event 3/31/2025
|
|
|
Matrix Capital Management Company, LP
13G
|
5.7% |
5/14/2025
Event 3/31/2025
|
|
| Matrix Capital Management Company, LP | 5.7% | ||
| David E. Goel | 5.7% | ||
|
GV 2019, L.P.
13G
|
5.5% |
5/9/2025
Event 3/31/2025
|
|
| GV 2019, L.P. | 4.1% | ||
| GV 2019 GP, L.P. | 4.1% | ||
| GV 2019 GP, L.L.C. | 4.1% | ||
| GV 2023, L.P. | 1.4% | ||
| GV 2023 GP, L.P. | 1.4% | ||
| GV 2023 GP, L.L.C. | 1.4% | ||
| Alphabet Holdings LLC | 5.5% | ||
| XXVI Holdings Inc. | 5.5% | ||
| Alphabet Inc. | 5.5% | ||
|
Third Rock Ventures IV, L.P.
13G
|
13.9% |
5/9/2025
Event 1/31/2025
|
|
| Third Rock Ventures IV, L.P. | 13.9% | ||
| Third Rock Ventures GP IV, L.P. | 13.9% | ||
| TRV GP IV, LLC | 13.9% | ||
| Third Rock Ventures V, L.P. | 2.2% | ||
| Third Rock Ventures GP V, L.P. | 2.2% | ||
| TRV GP V, LLC | 2.2% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 2
|
10.2% |
4/29/2025
Event 4/25/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 7.5% | ||
| FHMLSP, L.P. | 7.5% | ||
| FHMLSP, L.L.C. | 7.5% | ||
| Frazier Life Sciences Public Overage Fund, L.P. | 2.2% | ||
| FHMLSP Overage, L.P. | 2.2% | ||
| FHMLSP Overage, L.L.C. | 2.2% | ||
| Frazier Life Sciences X, L.P. | 0.2% | ||
| FHMLS X, L.P. | 0.2% | ||
| FHMLS X, L.L.C. | 0.2% | ||
| Frazier Life Sciences XI, L.P. | 0.3% | ||
| FHMLS XI, L.P. | 0.3% | ||
| FHMLS XI, L.L.C. | 0.3% | ||
| James N. Topper | 10.2% | ||
| Patrick J. Heron | 10.2% | ||
| Albert Cha | 9.7% | ||
| James Brush | 9.7% | ||
| Daniel Estes | 0.3% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
Amendment 1
|
9.4% |
4/29/2025
Event 3/31/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 7.0% | ||
| FHMLSP, L.P. | 7.0% | ||
| FHMLSP, L.L.C. | 7.0% | ||
| Frazier Life Sciences Public Overage Fund, L.P. | 2.1% | ||
| FHMLSP Overage, L.P. | 2.1% | ||
| FHMLSP Overage, L.L.C. | 2.1% | ||
| Frazier Life Sciences X, L.P. | 0.2% | ||
| FHMLS X, L.P. | 0.2% | ||
| FHMLS X, L.L.C. | 0.2% | ||
| Frazier Life Sciences XI, L.P. | 0.3% | ||
| FHMLS XI, L.P. | 0.3% | ||
| FHMLS XI, L.L.C. | 0.3% | ||
| James N. Topper | 9.4% | ||
| Patrick J. Heron | 9.4% | ||
| Albert Cha | 9.0% | ||
| James Brush | 9.0% | ||
| Daniel Estes | 0.3% | ||
|
Frazier Life Sciences Public Fund, L.P.
13G
|
7.3% |
2/10/2025
Event 2/3/2025
|
|
| Frazier Life Sciences Public Fund, L.P. | 5.4% | ||
| FHMLSP, L.P. | 5.4% | ||
| FHMLSP, L.L.C. | 5.4% | ||
| Frazier Life Sciences Public Overage Fund, L.P. | 1.6% | ||
| FHMLSP Overage, L.P. | 1.6% | ||
| FHMLSP Overage, L.L.C. | 1.6% | ||
| Frazier Life Sciences X, L.P. | 0.1% | ||
| FHMLS X, L.P. | 0.1% | ||
| FHMLS X, L.L.C. | 0.1% | ||
| Frazier Life Sciences XI, L.P. | 0.2% | ||
| FHMLS XI, L.P. | 0.2% | ||
| FHMLS XI, L.L.C. | 0.2% | ||
| James N. Topper | 7.3% | ||
| Patrick J. Heron | 7.3% | ||
| Albert Cha | 7.0% | ||
| James Brush | 7.0% | ||
| Daniel Estes | 0.2% | ||
|
Deep Track Capital, LP
13G
|
6.9% |
2/7/2025
Event 1/31/2025
|
|
| Deep Track Capital, LP | 6.9% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.9% | ||
| David Kroin | 6.9% | ||
|
Foresite Capital Fund IV, L.P.
13G
|
5.6% |
2/7/2025
Event 1/31/2025
|
|
| Foresite Capital Fund IV, L.P. | 4.8% | ||
| Foresite Capital Management IV, LLC | 4.8% | ||
| Foresite Capital Fund V, L.P. | 0.8% | ||
| Foresite Capital Management V, LLC | 0.8% | ||
| James Tananbaum | 5.6% | ||
|
Foresite Capital Fund IV, L.P.
13G
|
5.6% |
2/7/2025
Event 1/31/2025
|
|
| Foresite Capital Fund IV, L.P. | 4.8% | ||
| Foresite Capital Management IV, LLC | 4.8% | ||
| Foresite Capital Fund V, L.P. | 0.8% | ||
| Foresite Capital Management V, LLC | 0.8% | ||
| James Tananbaum | 5.6% |